Silence Therapeutics PLC (SLN) Stock Price, Quote, News & History

SLNNASDAQ
$10.32
-0.18-1.71%
Last update: Jul 20, 11:30 AM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-65.57M
Investing Cash Flow (TTM)
6.39M
Financing Cash Flow (TTM)
1.00K
Free Cash Flow (TTM)
-65.62M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-59.18M

Analyst Trends and Forecast

1
Mar
2
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$142.61M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
591.12
PB Ratio (TTM)
10.04
Earnings Yield % (TTM)
-15.43%
Earnings Yield % (FWD)
-13.03%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.05

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$5.66M
Debt to Equity
0.00
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$10.47
Close
-
Volume / Avg.
217.48K / 392.49K
Day Range
$10.16 - $10.74
52 Wk Range
4.19 - 11.19
Market Cap
$487.46M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
62
Short Interest
4.86%
Days to Cover
2.24

About

Sector
Health Care
Industry
Biotechnology
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates bot...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Silence Therapeutics (SLN) stock?

A

You can purchase shares of Silence Therapeutics (NASDAQ:SLN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Silence Therapeutics (SLN) competitors?

A

There are no as such competitors for Silence Therapeutics.

Q

What is the forecast, or price target, for Silence Therapeutics (SLN) stock?

A

Silence Therapeutics has a consensus price target of $39.67.

Q

What is the current price for Silence Therapeutics (SLN)?

A

The stock price for Silence Therapeutics (NASDAQ: SLN) is $10.32 last updated July 20, 2026 at 11:30 AM EDT.

Q

Does Silence Therapeutics (SLN) pay a dividend?

A

There are no upcoming dividends for Silence Therapeutics.

Q

When is Silence Therapeutics (NASDAQ:SLN) reporting earnings?

A

Silence Therapeutics does not have any upcoming earnings scheduled.

Q

Is Silence Therapeutics (SLN) going to split?

A

There is no upcoming split for Silence Therapeutics.

Q

What sector and industry does Silence Therapeutics (SLN) operate in?

A

Silence Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.